98%
921
2 minutes
20
Background: The discovery of new neurotransmitters is crucial for the in-depth understanding of neural signal transmission, neurological disorders, and relevant treatment strategies. Emerging evidence has indicated that harmine is an important endogenous compound, and its level is closely related to different physiological and disease states. Inspired by this, we propose a hypothesis that harmine may be a potential neurotransmitter or neuromodulator and display neurotransmitter or neuromodulator-like properties. This study aims to explore the potential properties of harmine as a neurotransmitter or neuromodulator according to the essential criteria for neurotransmitters and neuromodulators.
Methods: Candidate proteins for the biosynthesis of harmine were searched by local BLAST. The target protein was then recombinantly expressed, purified, and functionally validated. Subsequently, the release, metabolism, and uptake pathways of harmine were investigated using rat brain synaptosomes and primary neural cells through mass spectrometry analysis. A human proteome microarray was employed to screen for harmine-binding receptors, followed by experimental validation.
Results: Adipocyte plasma membrane-associated protein isoform X1 (APMAP-X1) could effectively catalyze the Pictet-Spengler reaction in mammals to generate tetrahydroharmine, which was subsequently oxidized by myeloperoxidase (MPO) to produce harmine. Moreover, harmine could be metabolized, taken up, and released within the synaptic cleft, fulfilling the conditions for clearance and release within the synaptic cleft. Harmine also regulated the expression of neurotransmitter transporters, implying its potential neuromodulatory properties. G protein-coupled receptor 85 (GPR85) and chloride intracellular channel 2 (CLIC2) were receptors targeted by harmine in the central nervous system. Functional verification results confirmed that harmine exerted an inhibitory effect on the GPR85 and could induce cellular depolarization.
Conclusion: Current findings provide preliminary evidence that harmine may exhibit neurotransmitter-like properties in certain respects and support its role as an endogenous neuromodulator. However, direct evidence supporting harmine as a neurotransmitter remains limited. Further studies are needed to clarify the precise mechanisms of harmine in neurotransmission. Our study provides a new perspective for researchers on exploring novel endogenous molecules and their significance in neurophysiology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277293 | PMC |
http://dx.doi.org/10.3389/fphar.2025.1588105 | DOI Listing |
Int Immunopharmacol
September 2025
Department of Pharmacy, General Hospital of Northern Theater Command, Shenyang 110016, P.R. China; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, 110016, Shenyang, P.R. China. Electronic address:
Background: Acinetobacter baumannii (Ab), especially extensively drug-resistant Ab strains (XDR-Ab), poses a significant threat to clinical medicine due to its high mortality rate and limited treatment options. Harmine derivatives exhibit potent anti-inflammatory and immunomodulatory effects. In this study, we aimed to investigate whether the harmine derivative ZLWH-38 combined with colistin could enhance therapeutic efficacy against XDR-Ab pneumonia by suppressing inflammatory responses.
View Article and Find Full Text PDFbioRxiv
August 2025
Department of Pharmacology University of Virginia, Charlottesville VA, USA.
The adult mammalian heart has a limited ability to regenerate lost myocardium following myocardial infarction (MI), largely due to the poor proliferative capacity of cardiomyocytes. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a known regulator of cell quiescence, though the mechanisms underlying its function remain unclear. Previous studies have shown that pharmacological inhibition of DYRK1A using harmine induces cardiomyocyte cell cycle re-entry after ischemia/reperfusion (I/R) MI.
View Article and Find Full Text PDFBiochem Pharmacol
August 2025
Beijing University of Chinese Medicine, Beijing 102400, China. Electronic address:
KRAS is the most frequent RAS mutation in pancreatic cancer (PC). Recently, small molecule inhibitors like MRTX1133, which target KRAS , have shown efficacy in inhibiting PC growth. However, the development of intrinsic and acquired resistance to these inhibitors has been observed, necessitating the identification of novel therapeutic targets.
View Article and Find Full Text PDFBrain Res Bull
August 2025
Department of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830063, china; Xinjiang Key Laboratory of Neurological Disease Research, Urumqi, Xinjiang, 830063, China; Xinjiang Medical University, Urumqi, Xinjiang, 830018, China. Electronic address: poplar
The dual specificity tyrosine-regulated kinase 1a (DYRK1A) gene plays a crucial role in developing midbrain dopamine neurons. DYRK1A is closely related to Parkinson's disease(PD), and there are not many relevant studies. This paper focuses on the potential role of DYRK1A in the initiation and progression of PD and the discovery of therapeutic targets for PD.
View Article and Find Full Text PDFCJEM
August 2025
Department of Emergency Medicine, BIDMC Disaster Medicine Fellowship, Boston, MA, USA.